Idan ka sha NMN ko NR don riƙe tsoka yayin tsufa, da alama kana tunanin NAD+ zai shiga kai tsaye cikin ƙwayoyin tsoka. Sabon binciken berayen ya nuna cewa labarin na iya zama daban. Rabi daga fa'idar ya fara ne a mai kitse, wanda ke amsa ƙara NAD+ ta hanyar aika saƙon kariya ta jini zuwa ga tsoka.
Wannan bincike ne na dabbobi. Ba ya ba mu tabbataccen shaida kan abin da NMN ko NR za su yi a mutane, amma yana ba da haske kan yadda NAD+ ke hulɗa tsakanin gabobi.
Ban mamaki: Saƙon Da Ke Fitowa Daga Kitse
Takardar da aka wallafa a Cell Metabolism daga Liang, Li da abokan aiki a Chinese Academy of Medical Sciences da Peking Union Medical College ta fara da matsala da aka saba gani: rashin ƙwayar tsoka (muscle atrophy) babba ne dalilin rauni da nakasa a tsufa. Masana har yanzu ba su fahimci yadda alamu na jiki ke kare tsoka ba.
Kungiyar ta gano Serpina3n, wani adipokine (sinadarin sadarwa da kitse ke sakin), a matsayin muhimmin wakilin kariyar tsoka da ke tasiri daga ƙara NAD+ a cikin kitse.
Tsarin da aka ba da shawara, kamar yadda ke a cikin takaitaccen rubutu:
- NAD+ ya ƙaru a adipose tissue (kitse).
- Wannan yana kunna rubutun STAT1‑dependent na gene Serpina3n.
- Serpina3n yana fitowa zuwa bloodstream (jini).
- Tsoka na samun kariya daga atrophy.
Wannan hoton ya bambanta da na al'ada, inda ake ganin NAD+ precursors suna aiki a cikin ƙwayar tsoka kawai. Anan, kitse yana aiki a matsayin “masanin alamu” da ke canza siginar ƙwayoyin halitta zuwa ga tsoka.
Kariya A Kan Nau’i Uku Na Rasa Tsoka
An nuna tasirin kariya a cikin yanayi uku: tsufa, rashin motsa jiki, da cancer cachexia. Waɗannan yanayi na da bambance‑bambancen muhimmi:
- Rashin tsoka saboda tsufa yana faruwa a hankali, yana haɗa da canje‑canjen hormone, kumburi da metabolism.
- Atrophy na rashin amfani na faruwa bayan rashin motsi ko dakatar da jiki, kamar kwanciyar gado ko riƙe da cast.
- Cancer cachexia wata cuta ce mai tsanani wadda ke haifar da ɓarnatar jiki sakamakon kumburin da ke tattare da ciwon daji da matsalolin metabolism.
Wani tsari guda ɗaya ne ya bayyana a cikin duka uku, wato tasirin Serpina3n a kan tsoka. Takaitaccen rubutun ba ya fayyace girman tasirin a kowane yanayi, don haka ba za a iya tantance ƙarfi na kariya ba daga wannan taƙaitawa kawai. Haka kuma, samfuran berayen ba su daidai da yanayin ɗan adam.
Abin Da Serpina3n Ke Yi A Cikin Tsoka
Lokacin da Serpina3n ta kai ga tsoka, marubutan sun lura cewa yana kiyaye matakan sinadarin pyruvate carboxylase. Pyruvate carboxylase na ɗaya daga cikin enzayim ɗin mitochondria da ke ba da gudummawa ga TCA cycle, wato hanyar samar da makamashi a tsakiya. Wannan aikin ana kiransa anaplerosis.
A taƙaice, TCA cycle na buƙatar ci gaba da samun abubuwa na tsaka‑tsaki, kuma anaplerosis ke cike su. Bisa ga marubutan, kiyaye pyruvate carboxylase yana tallafa wa:
- anaplerosis,
- oxidative metabolism,
- protein synthesis.
Wannan ya dace da ra'ayin da ke cewa ɓarnatar tsoka wani ɓangare ne na matsalar metabolism. Idan samar da makamashi da gina‑gine na sel ya samu tangarda, raguwar furotin na iya wuce gina furotin. Serpina3n na taimakawa wajen riƙe wannan tsarin.
Takardar Haƙƙin Mallaka Da Abin Da Take Nuna
Bayanan rikicin sha’awa sun nuna cewa marubuta uku (J.L., N.L., J.H.) sun nemi takardar haƙƙin mallaka na wucin gadi kan amfani da Serpina3n a matsayin hanya don magance atrophy na tsoka. Wannan abu ne da ake gani a binciken fassara kuma ba ya kawar da sakamakon, amma yana nuna inda marubutan ke ganin damar kasuwanci: wani tsarin da aka gina da sinadarin furotin, ba ƙara ba. Sake gwada sakamakon zai zama muhimmi.
Abin Da Wannan Ke Nufi Ga Masu Shan NMN Da NR
Yana da sauƙi a ɗauki wannan a matsayin hujja don ƙara amincewa da ƙara. Amma a yi hankali.
Abin da yake nuna:
- Ilimin NAD+ na iya aiki ta hanyar sadarwa tsakanin gabobi, ba kawai tasirin kai tsaye a tsoka ba.
- Kitse na iya zama muhimmin ɓangare da aka watsi da shi wajen tasirin ƙara NAD+ a kan tsoka.
Abin da ba ya nuna:
- Ba ya nuna cewa shan NMN ko NR yana ƙara Serpina3n a cikin mutane. Takaitaccen rubutun ba ya magana kan ƙimar ɗan adam, kuma babu abin da ya kamata a ɗauka.
- Ba ya nuna cewa kowace ƙima, nau'i ko jadawalin zai kare tsoka a ɗan adam.
- Ba ya tabbatar da cewa Serpina3n yana aiki daidai a ɗan adam, ko cewa yana da aminci a ƙara shi.
Binciken yana kan beraye ne kawai, kuma takaitaccen rubutun ba ya ba da bayanan ɗan adam. Yawancin sakamakon da ke da alƙawari a beraye ba su kai ga ɗan adam ba, saboda bambance‑bambancen metabolism da yanayin jiki.
Haɗa Da Horon Ƙarfi
Babu wani ɓangare a cikin wannan takarda da ya gwada motsa jiki, don haka duk wata alaka da horo ta zo ne daga tunani. Duk da haka, a wasu bincike an tabbatar cewa horon ƙarfi da isasshen shan furotin su ne manyan hanyoyi da suka tabbatar da riƙe tsoka yayin tsufa. Idan wani ƙara zai taimaka, zai zama ƙari ne kawai ga waɗannan ginshiƙai, ba maye gurbinsu ba.
Hakanan ya dace da cewa rashin amfani shine ɗaya daga cikin yanayin da aka bincika. Kasancewa mai motsi shine hanya mafi kai tsaye don kauce wa atrophy na rashin amfani, duk da yadda NAD+ ke tafiyarwa.
Tambayoyi Da Ke Buɗe
- Shin NAD+ precursors na ƙara Serpina3n a cikin kitse na ɗan adam? Takaitaccen rubutun ba ya amsa, kuma wannan shi ne muhimmin tambaya.
- Shin akwai daidaito a ɗan adam? Serpina3n sinadari ne na bera; mafi kusa da shi a ɗan adam shi ne SERPINA3, amma ba a tabbatar da tasirin sa ba.
- Shin ƙara Serpina3n na da aminci na dogon lokaci? Serpins suna sarrafa proteases da ƙumburi, don haka ƙara su a jiki gaba ɗaya na iya haifar da sakamako marasa so.
- Ta yaya yanayin jiki ke tasiri? Idan kitse ne tushen, mutanen da ke da ƙananan kitse ko manyan kitse, ko waɗanda ke da matsalolin kitse, na iya amsa daban.
- Shin yana ƙara wa horo? Za a buƙaci gwaje‑gwaje masu haɗa su.
Gabaɗaya
Wannan bincike ya gabatar da sabon ra'ayi: NAD+ na iya kare tsoka ta hanyar ƙarfafa kitse ya saki Serpina3n, wanda ke taimaka wa tsoka ta riƙe muhimmin enzayim na metabolism da ci gaba da gina furotin. Wannan wani bincike ne na beraye na ƙirar ƙwaya, ba jagorar ƙara ba. Don yanzu, abin da ya kamata a ɗauka shine sha'awa kawai: ci gaba da yin horo, cin abinci mai furotin, kuma a ɗauki NMN da NR a matsayin ƙari da ba a tabbatar da tasirinsa a ɗan adam ba har sai an samu bayanan likita.